 | • レポートコード：MRC2303F0061 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、241ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：化学 |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の本調査資料によると、2021年に694.30百万ドルであった世界の合成ホルモン市場規模が、2022年に789.70百万ドルになり、予測期間中（〜2027年）にCAGR13.99%で成長し1,523.58百万ドルまで達すると展望されています。本書は、合成ホルモンの世界市場について総合的に分析し、市場規模・動向・予測などを整理しています。序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、製品別（アミノ酸誘導体、ペプチドホルモン、ステロイドホルモン）分析、投与経路別（静脈内投与、鼻、経口、坐薬、局所投与）分析、用途別（成長ホルモン欠乏、男性性腺機能低下症、更年期障害、甲状腺ホルモン欠乏症）分析、エンドユーザー別（病院薬局、小売薬局、オンライン薬局）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況、企業情報など、以下の構成で掲載しています。また、主要企業として、Acerus Pharmaceuticals Corporation、American Regent, Inc.、BioTE Medical、Endo Pharmaceuticals Inc.、Ferring B.V.、IBSA Institute Biochimique SA、Lupin Pharmaceuticals, Inc.、Lyndra Therapeutics, Inc.、McGuff Pharmaceuticals, Inc.、Pfizer Inc.、Slayback Pharma LLC、SottoPelleなどの情報が含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の合成ホルモン市場規模：製品別 - アミノ酸誘導体の市場規模 - ペプチドホルモンの市場規模 - ステロイドホルモンの市場規模 ・世界の合成ホルモン市場規模：投与経路別 - 静脈内投与における市場規模 - 鼻投与における市場規模 - 経口投与における市場規模 - 坐薬投与における市場規模 - 局所投与における市場規模 ・世界の合成ホルモン市場規模：用途別 - 成長ホルモン欠乏における市場規模 - 男性性腺機能低下症における市場規模 - 更年期障害における市場規模 - 甲状腺ホルモン欠乏症における市場規模 ・世界の合成ホルモン市場規模：エンドユーザー別 - 病院薬局における市場規模 - 小売薬局における市場規模 - オンライン薬局における市場規模 ・世界の合成ホルモン市場規模：地域別 - 南北アメリカの合成ホルモン市場規模 アメリカの合成ホルモン市場規模 カナダの合成ホルモン市場規模 ブラジルの合成ホルモン市場規模 … - アジア太平洋の合成ホルモン市場規模 日本の合成ホルモン市場規模 中国の合成ホルモン市場規模 インドの合成ホルモン市場規模 韓国の合成ホルモン市場規模 台湾の合成ホルモン市場規模 … - ヨーロッパ/中東/アフリカの合成ホルモン市場規模 イギリスの合成ホルモン市場規模 ドイツの合成ホルモン市場規模 フランスの合成ホルモン市場規模 ロシアの合成ホルモン市場規模 … - その他地域の合成ホルモン市場規模 ・競争状況 ・企業情報 |
The Global Synthetic Hormones Market size was estimated at USD 694.30 million in 2021 and expected to reach USD 789.70 million in 2022, and is projected to grow at a CAGR 13.99% to reach USD 1,523.58 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Synthetic Hormones to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Product Type, the market was studied across Amino Acid Derivatives, Peptide Hormone, and Steroid Hormones.
Based on Route of Administration, the market was studied across Intravenous, Nasal, Oral, Suppository, and Topical.
Based on Application, the market was studied across Growth Hormone Deficiency, Male Hypogonadism, Menopause, and Thyroid Hormone Deficiency.
Based on End-User, the market was studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Synthetic Hormones market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Synthetic Hormones Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Synthetic Hormones Market, including Acerus Pharmaceuticals Corporation, American Regent, Inc., BioTE Medical, Endo Pharmaceuticals Inc., Ferring B.V., IBSA Institute Biochimique SA, Lupin Pharmaceuticals, Inc., Lyndra Therapeutics, Inc., McGuff Pharmaceuticals, Inc., Pfizer Inc., Slayback Pharma LLC, and SottoPelle.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Synthetic Hormones Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Synthetic Hormones Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Synthetic Hormones Market?
4. What is the competitive strategic window for opportunities in the Global Synthetic Hormones Market?
5. What are the technology trends and regulatory frameworks in the Global Synthetic Hormones Market?
6. What is the market share of the leading vendors in the Global Synthetic Hormones Market?
7. What modes and strategic moves are considered suitable for entering the Global Synthetic Hormones Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Surge in the incidence of hormonal imbalance in the population
5.1.1.2. Rise in prevalence of thyroid-related diseases and increase in health care expenditure
5.1.1.3. Rapid rise in the awareness among consumers about bioidentical hormones
5.1.2. Restraints
5.1.2.1. High cost involved in hormonal replacement therapy
5.1.3. Opportunities
5.1.3.1. Increase in research & development of new products by manufacturers
5.1.3.2. Rising incidence of irregular menstrual cycles
5.1.4. Challenges
5.1.4.1. Certain side-effects related to hormones
5.2. Cumulative Impact of COVID-19
6. Synthetic Hormones Market, by Product Type
6.1. Introduction
6.2. Amino Acid Derivatives
6.3. Peptide Hormone
6.4. Steroid Hormones
7. Synthetic Hormones Market, by Route of Administration
7.1. Introduction
7.2. Intravenous
7.3. Nasal
7.4. Oral
7.5. Suppository
7.6. Topical
8. Synthetic Hormones Market, by Application
8.1. Introduction
8.2. Growth Hormone Deficiency
8.3. Male Hypogonadism
8.4. Menopause
8.5. Thyroid Hormone Deficiency
9. Synthetic Hormones Market, by End-User
9.1. Introduction
9.2. Hospital Pharmacies
9.3. Online Pharmacies
9.4. Retail Pharmacies
10. Americas Synthetic Hormones Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Synthetic Hormones Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Synthetic Hormones Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis, By Key Player
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion
14. Company Usability Profiles
14.1. Acerus Pharmaceuticals Corporation
14.1.1. Business Overview
14.1.2. Key Executives
14.1.3. Product & Services
14.2. American Regent, Inc.
14.2.1. Business Overview
14.2.2. Key Executives
14.2.3. Product & Services
14.3. BioTE Medical
14.3.1. Business Overview
14.3.2. Key Executives
14.3.3. Product & Services
14.4. Endo Pharmaceuticals Inc.
14.4.1. Business Overview
14.4.2. Key Executives
14.4.3. Product & Services
14.5. Ferring B.V.
14.5.1. Business Overview
14.5.2. Key Executives
14.5.3. Product & Services
14.6. IBSA Institute Biochimique SA
14.6.1. Business Overview
14.6.2. Key Executives
14.6.3. Product & Services
14.7. Lupin Pharmaceuticals, Inc.
14.7.1. Business Overview
14.7.2. Key Executives
14.7.3. Product & Services
14.8. Lyndra Therapeutics, Inc.
14.8.1. Business Overview
14.8.2. Key Executives
14.8.3. Product & Services
14.9. McGuff Pharmaceuticals, Inc.
14.9.1. Business Overview
14.9.2. Key Executives
14.9.3. Product & Services
14.10. Pfizer Inc.
14.10.1. Business Overview
14.10.2. Key Executives
14.10.3. Product & Services
14.11. Slayback Pharma LLC
14.11.1. Business Overview
14.11.2. Key Executives
14.11.3. Product & Services
14.12. SottoPelle
14.12.1. Business Overview
14.12.2. Key Executives
14.12.3. Product & Services
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing